AbbVie gains after lifting FY profit forecast
** Shares of drugmaker AbbVie ABBV.N rise 1.5% to $294.79; hit record high
** Forecasts FY adj EPS of $13.95 to $13.99, compared with its prior outlook of $13.76 to $13.96
** Reports Q3 EPS of $3.82, above analysts' expectations of $3.75, according to data compiled by LSEG
** 26 of 32 brokerages rate the stock "buy" or higher, and 6 "hold"; their median PT is $289 - data compiled by LSEG
** Including session moves, stock has risen about 30% YTD